Our findings offer new mechanistic insights into the regulation of cholesterol biosynthesis during viral infection and suggest that targeting RORγ could provide a promising strategy for developing novel antiviral therapies against IAV and potentially other emerging viral threats. This evidence concerns the gene RORC and viral infectious disease.